At
Pharmidex, we stand in solidarity with all patients, families, and healthcare professionals impacted by blood cancers.
This day is a powerful reminder of the urgent need for continued innovation, collaboration, and compassion in the fight against these life-threatening diseases.
Through our cutting-edge preclinical services, including:
- PK/ADME studies
- CNS penetration & efficacy models
- in vivo/in vitro pharmacology
- bioanalytical and regulatory support
we contribute to the development of safer, more effective therapies for blood cancers.
🧬 We’re proud to collaborate with leading biopharma companies, academic institutions, and charities to accelerate the discovery and delivery of new treatments.
❤️ Today, we renew our commitment to this mission working towards a future where every patient has access to a cure.
🔗 Learn more and support the cause: https://www.dkms.org.uk
